Edition:
India

China National Medicines Corp Ltd (600511.SS)

600511.SS on Shanghai Stock Exchange

26.53CNY
19 Jan 2018
Change (% chg)

¥-0.45 (-1.67%)
Prev Close
¥26.98
Open
¥26.98
Day's High
¥27.11
Day's Low
¥26.38
Volume
5,666,355
Avg. Vol
3,650,967
52-wk High
¥36.90
52-wk Low
¥25.21

Chart for

About

China National Medicines Corporation Ltd. is a China-based company principally engaged in the distribution of pharmaceutical products. The Company's primary products include proprietary Chinese medicines, chemical medicine preparations, chemical raw materials, antibiotics, biochemical drugs, biological products, narcotic drugs,... (more)

Overall

Beta: 0.89
Market Cap(Mil.): ¥22,877.63
Shares Outstanding(Mil.): 766.93
Dividend: 0.20
Yield (%): 0.67

Financials

  Industry Sector
P/E (TTM): -- 21.06 16.58
EPS (TTM): -- -- --
ROI: -- 11.81 10.60
ROE: -- 13.97 14.19

BRIEF-China National Medicines elects chairman

* SAYS BOARD ELECTS JIANG XIUCHANG AS CHAIRMAN, REPLACING LIU YONG Source text in Chinese: http://bit.ly/2BWadoE Further company coverage: (Reporting by Hong Kong newsroom)

12 Dec 2017

BRIEF-China National Medicines' 9-month net profit up 9.1 pct y/y

* Says 9-month net profit up 9.1 percent y/y a t 835.8 million yuan ($125.83 million)

25 Oct 2017

BRIEF-China National Medicines Corp to provide loan of up to 400 mln yuan to controlling bio-medicine unit

* Says it plans to provide loan of up to 400 million yuan to Beijing-based controlling biological medicine subsidiary

23 Aug 2017

BRIEF-China National Medicines' H1 net profit up 10.8 pct y/y

* Says H1 net profit up 10.8 percent y/y at 553.9 million yuan ($83.14 million)

22 Aug 2017

Earnings vs. Estimates